Influx Healthtech Limited (NSE: INFLUX) is a Mumbai, Maharashtra-based company in the Domestic contract manufacturers industry. With a market capitalisation of ₹588 Cr, it ranks #1,911 by market cap among the 6,197 Indian listed companies on FinBizNet, and #4 of 4 in Domestic contract manufacturers. At ₹268.00 (as of 19 Nov 2026), the share price is 0.7% below its 52-week high of ₹270.00 and 2.5% above its 52-week low of ₹261.50.
| Current Price | ₹268.00 |
|---|---|
| Market Cap | ₹588 Cr |
| NSE Symbol | INFLUX |
| Sector | Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Life Sciences Tools and Services |
| Sub-Industry | Life Sciences Tools and Services > Domestic contract manufacturers |
| P/E Ratio | 28.7 |
| Return on Equity | 20.39% |
| Return on Assets | 16.83% |
| 52-Week Range | ₹261.50 – ₹270.00 |
| Beta (1Y) | -0.03 |
| Headquarters | Mumbai, Maharashtra |
| Website | influxhealthtech.com |
Promoters held 73.53% of Influx Healthtech Limited's shares as of Sept 2026, unchanged from Sept 2025.
Influx Healthtech Limited operates as a contract development and manufacturing organization that provides a range of healthcare products in India. The company offers ayurvedic and herbal formulations in form of tablets, capsules, powders, liquid orals, ointments, creams, lotions, and other applications; veterinary feed supplements in form of tablets, liquid orals, oral sprays, powders, bolus, gels, ointments, and creams for animals; and home care products, including bathroom cleaners, floor cleansers, phenyle liquids, and other household cleaning products. It also provides dietary and nutritional supplements in the form of tablets, capsules, powders, liquid orals, softgels, lozenges, jellies, gummies, oral dispersible films, candies, gym/sports supplements, effervescent tablets, and liquid fill capsules; and cosmetics products, such as skin, body care, hair care, beard care, and face mask products, as well as soaps for men and women. The company also exports its products. Influx Health
1. Vitamins & Nutrition Products-This segment operates as a contract development and manufacturing organization that produces dietary and nutritional supplements, cosmetics, ayurvedic/herbal products, veterinary feed supplements, homecare products, active pharmaceutical ingredients, and finished dosage forms, including tablets, capsules, and injectables. 2. NA-NA 3. NA-NA 4. NA-NA
1. Vitamins & Nutrition Products-100%
| Company | Market Cap | P/E | ROE | Latest Qtr Revenue | 1Y Change |
|---|---|---|---|---|---|
| Akums Drugs and Pharmaceuticals Limited | ₹11,787 Cr | 45 | 8.02% | ₹1,342 Cr | +57.3% |
| INNOVA CAPTAB LIMITED | ₹6,249 Cr | 47.3 | 14.03% | ₹496 Cr | +37.2% |
| Windlas Biotech Ltd | ₹2,060 Cr | 32.6 | 12.23% | ₹264 Cr | +18.9% |
| Influx Healthtech Limited | ₹588 Cr | 28.7 | 20.39% | — | — |
Listed by market capitalisation. Ratios are shown for context only.
Influx Healthtech Limited is trading at ₹268.00, with a market capitalisation of ₹588 Cr.
Influx Healthtech Limited operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Life Sciences Tools and Services space (Life Sciences Tools and Services > Domestic contract manufacturers).
Influx Healthtech Limited has a P/E of 28.7 and a return on equity of 20.39%.
Influx Healthtech Limited is listed on the NSE under the symbol INFLUX.
Promoters held 73.53% of Influx Healthtech Limited's shares as of Sept 2026, unchanged from Sept 2025.
Data as of 19 Nov 2026. Descriptive market data only — not investment advice.